About us

Who we are

Vaccines Europe is a specialised vaccines group within the European Federation of Pharmaceutical Industries and Associations (EFPIA), the professional association of the research-based pharmaceutical industry in Europe.

Vaccines Europe was created in 1991 to provide a voice for the vaccine industry in Europe. The group represents vaccine companies of all sizes operating in Europe, and currently includes all the major global innovative and research-based vaccine companies, including small and medium-sized enterprises.

In 2021, Vaccines Europe marked its 30^th anniversary, with members sharing their most memorable moments of the last three decades. Read the stories here.

Our mission

Our mission is to foster innovation and value recognition of lifecourse immunisation in Europe to protect people against evolving health challenges.

2021

30 th

Anniversary

Vaccines Europe, the specialised vaccines group within the European Federation of Pharmaceutical Industries and Associations (EFPIA), was created in 1991 and celebrates its 30th anniversary this year.

Vaccines Europe represents vaccine companies of all sizes operating in Europe, and currently our membership includes all the major global innovative and research-based vaccine companies, including small and medium-sized enterprises.

Vaccines are one of the most cost-effective public health tools, saving lives of individuals from birth to grave, saving costs to the society from health care systems to the whole economy and supporting freedom of being and movement. In addition and often forgotten or not known, vaccines contribute to the fight against AMR and vaccine-preventable cancers. Overall, vaccines are an instrumental public health tool to build resilient health care systems and economies.

With 30 years of continuous innovation against burdensome when not lethal vaccine-preventable diseases, Vaccines Europe represents today 14 vaccine companies, supports the value of about 20 vaccines available for routine use in Europe, has demonstrated to be a reliable innovation-driven industrial partner throughout 2 pandemics in the last 10 years (H1N1 – 2009-2010 and COVID-19 – 2020-2021), as well as the vaccine-hesitancy induced measles outbreak of 2017-2019, and is prepared to continue protecting the population with safe and efficacious innovative vaccines against more vaccine-preventable diseases over the next decades.

Throughout the next months, listen to our members to know more about what has been achieved over the last 30 years in the fight against vaccine-preventable diseases, and what can be expected for the next 30 years.

Sibilia Quilici, Executive Director Vaccines Europe

#WeWontRest #VaccinesWork #TeamVaccines

Read the stories

Vaccines Today

Vaccines Today is an online platform for discussing vaccines and vaccination. The target audience is the general public and others in Europe with an interest in immunisation.

The European
Vaccine Industry
in figures

This infographic shows the impact and reach of our industry across Europe.

EFPIA

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the biopharmaceutical industry operating in Europe. Through its direct membership of 37 national associations, 38 leading pharmaceutical companies and a growing number of small and medium-sized enterprises (SMEs), EFPIA’s mission is to create a collaborative environment that enables our members to innovate, discover, develop and deliver new therapies and vaccines for people across Europe, as well as contribute to the European economy.